[go: up one dir, main page]

HK1018591B - 酞胺哌啶酮用於免疫疾病之治疗的静脉内形式 - Google Patents

酞胺哌啶酮用於免疫疾病之治疗的静脉内形式 Download PDF

Info

Publication number
HK1018591B
HK1018591B HK99103610.6A HK99103610A HK1018591B HK 1018591 B HK1018591 B HK 1018591B HK 99103610 A HK99103610 A HK 99103610A HK 1018591 B HK1018591 B HK 1018591B
Authority
HK
Hong Kong
Prior art keywords
thalidomide
solution
therapy
aqueous
intravenous administration
Prior art date
Application number
HK99103610.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1018591A1 (zh
Inventor
Bjorkman Sven
Hoglund Peter
Eriksson Tommy
Original Assignee
Grunenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19743968A external-priority patent/DE19743968C2/de
Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh
Publication of HK1018591A1 publication Critical patent/HK1018591A1/zh
Publication of HK1018591B publication Critical patent/HK1018591B/zh

Links

HK99103610.6A 1997-10-06 1999-08-20 酞胺哌啶酮用於免疫疾病之治疗的静脉内形式 HK1018591B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743968A DE19743968C2 (de) 1997-10-06 1997-10-06 Intravenöse Applikationsform von Thalidomid zur Therapie immunologischer Erkrankungen
DE19743968 1997-10-06

Publications (2)

Publication Number Publication Date
HK1018591A1 HK1018591A1 (zh) 1999-12-30
HK1018591B true HK1018591B (zh) 2003-07-11

Family

ID=

Similar Documents

Publication Publication Date Title
US4861797A (en) Liquid ibuprofen compositions and methods of making them
DE2804457C2 (de) Immunsuppressive Mittel
US6124322A (en) Intravenous form of thalidomide for treating immunological diseases
CH640140A5 (de) Verfahren zur herstellung von intravenoes injizierbarem gamma-globulin.
JP2018516281A (ja) 安定なカンナビノイド製剤
EP0165474A1 (de) Immunstimulierende Mittel
JP3140409B2 (ja) 安定なプロスタグランジンｅ１−含有注射剤組成物
CH629668A5 (de) Verfahren zum reinigen von hepatitis-b-antigen.
US4847297A (en) Use of penicillamine for treating immune damaging illnesses
RU2238727C2 (ru) Стабильный водный раствор ем 12
EP0609701A1 (en) L-cystein, L-cystine or L-glutamine as a supplementary therapeutic agent for the treatment of immunodeficiency syndrome
HK1018591B (zh) 酞胺哌啶酮用於免疫疾病之治疗的静脉内形式
KR910005886A (ko) 안정화 백혈구 인터페론
CA1277240C (fr) Medicament modulateur de l'immunite et son procede de preparation
JP2003528134A (ja) 白血球産生の刺激用および腫瘍および原虫症の治療用およびダニ症、節足動物媒介感染の治療用医薬組成物およびその製法
DE2731736A1 (de) 5-m-tolyloxyuracil, verfahren zu dessen herstellung und dessen verwendung als arzneimittel zur behandlung von magengeschwueren
RU2813197C1 (ru) Лекарственная форма для подавления бактериальных инфекций, способ её организации
DE2201350A1 (de) Aufhebung der immunsuppressiven wirkung von corticoiden
DE3884878T2 (de) Uricosuretische Zusammensetzung.
JP2889491B2 (ja) 血圧降下剤
CN1554336A (zh) 水溶性青蒿素制剂的制备方法
DE69104638T2 (de) Neue Komplexe der Tiaprofensäure oder ihrer unlöslichen oder zum Teil löslichen Ester mit den Cyclodextrinen oder ihren Derivaten.
SU1194418A1 (ru) Способ лечени детей с острой гнойной деструктивной пневмонией
AU622427B2 (en) Liquid ibuprofen compositions and methods of making them
WO2023219529A1 (ru) Лекарственная форма для подавления бактериальных инфекций, способ её организации